Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 361

8.

A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)-Derived Analysis.

Mauri F, Maggioni AP, Franzosi MG, de Vita C, Santoro E, Santoro L, Giannuzzi P, Tognoni G.

J Am Coll Cardiol. 1994 Sep;24(3):600-7. Erratum in: J Am Coll Cardiol 1995 Mar 1;25(3):805.

10.

Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.

Weaver WD, White HD, Wilcox RG, Aylward PE, Morris D, Guerci A, Ohman EM, Barbash GI, Betriu A, Sadowski Z, Topol EJ, Califf RM.

JAMA. 1996 Mar 13;275(10):777-82.

PMID:
8598594
12.
13.
14.

Current issues concerning thrombolytic therapy for acute myocardial infarction.

Hennekens CH, O'Donnell CJ, Ridker PM, Marder VJ.

J Am Coll Cardiol. 1995 Jun;25(7 Suppl):18S-22S. Review.

15.

Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).

Tatu-Chiţoiu G, Teodorescu C, Dan M, Guran M, Căpraru P, Istrăţescu O, Tatu-Chiţoiu A, Bumbu A, Chioncel V, Arvanitopol S, Dorobanţu M.

Rom J Intern Med. 2004;42(3):557-73.

PMID:
16366130
16.

Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis. Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) Data Base.

Volpi A, de Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Sontoro E, Tavazzi L, Tognoni G.

J Am Coll Cardiol. 1994 Sep;24(3):608-15.

17.

[Tissue-type plasminogen activator (t-PA): comments on results of the GISSI-2 study].

Turazza FM.

Medicina (Firenze). 1990 Apr-Jun;10(2):193-4. Italian.

PMID:
2125681
19.

A prospective, randomized trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Kentucky Acute Myocardial Infarction Trial (KAMIT) Group.

Grines CL, Nissen SE, Booth DC, Gurley JC, Chelliah N, Wolf R, Blankenship J, Branco MC, Bennett K, DeMaria AN.

Circulation. 1991 Aug;84(2):540-9.

PMID:
1907228

Supplemental Content

Support Center